Aldehyde dehydrogenase type 2 activation by adenosine and histamine inhibits ischemic norepinephrine release in cardiac sympathetic neurons: mediation by protein kinase Cε

Journal of Pharmacology and Experimental Therapeutics

Volumn 343, Issue 1, 2012, Pages 97-105

  Robador, Pablo A ^a   Seyedi, Nahid ^a   Chan, Noel Yan Ki ^a   Koda, Kenichiro ^a   Levi, Roberto ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A3 RECEPTOR; ALDEHYDE DEHYDROGENASE ISOENZYME 2; HISTAMINE; HISTAMINE H3 RECEPTOR; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; NORADRENALIN; PROTEIN KINASE C EPSILON;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSFECTION; GUINEA PIG; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HISTAMINE RELEASE; HYPOXIA; INCUBATION TIME; INHIBITION KINETICS; ISOLATED HEART; MALE; NERVE ENDING; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SYMPATHETIC NERVE CELL; SYNAPTOSOME;

ALDEHYDE DEHYDROGENASE; ANIMALS; ANOXIA; ENZYME ACTIVATION; GUINEA PIGS; MITOCHONDRIAL PROTEINS; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; NOREPINEPHRINE; PC12 CELLS; PROTEIN KINASE C-EPSILON; RATS; RECEPTORS, HISTAMINE; RECEPTORS, PURINERGIC P1; SYMPATHETIC FIBERS, POSTGANGLIONIC; SYNAPTOSOMES;

EID: 84866328066     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.196626     Document Type: Article

References (36)

1. Aloyo VJ, McIlvain HB, Bhavsar VH, and Roberts J (1991) Characterization of norepinephrine accumulation by a crude synaptosomal-mitochondrial fraction isolated from rat heart. Life Sci 48:1317-1324.
2. 2B adenosine receptor agonists. Purinergic Signal 4:287-303.
3. Barbier AJ, Berridge C, Dugovic C, Laposky AD, Wilson SJ, Boggs J, Aluisio L, Lord B, Mazur C, Pudiak CM, et al. (2004) Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist. Br J Pharmacol 143:649-661. (Pubitemid 39524283)
4. + overload. Biochim Biophys Acta 1502:508-514.
5. Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, and Mochly-Rosen D (2008) Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321:1493-1495.
6. Cordis GA, Maulik N, Bagchi D, Engelman RM, and Das DK (1993) Estimation of the extent of lipid peroxidation in the ischemic and reperfused heart by monitoring lipid metabolic products with the aid of high-performance liquid chromatography. J Chromatogr 632:97-103. (Pubitemid 23066000)
7. Corti F, Olson KE, Marcus AJ, and Levi R (2011) The expression level of ecto-NTP diphosphohydrolase1/CD39 modulates exocytotic and ischemic release of neurotransmitters in a cellular model of sympathetic neurons. J Pharmacol Exp Ther 337:524-532.
8. Dorn GW 2nd, Souroujon MC, Liron T, Chen CH, Gray MO, Zhou HZ, Csukai M, Wu G, Lorenz JN, and Mochly-Rosen D (1999) Sustained in vivo cardiac protection by a rationally designed peptide that causes ε protein kinase C translocation. Proc Natl Acad Sci U S A 96:12798-12803. (Pubitemid 29513582)
9. Eade NR (1959) Mechanism of sympathomimetic action of aldehydes. J Pharmacol Exp Ther 127:29-34.
10. Eaton P, Li JM, Hearse DJ, and Shattock MJ (1999) Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart. Am J Physiol Heart Circ Physiol 276:H935-H943. (Pubitemid 29157466)
11. 2+ channels. J Pharmacol Exp Ther 269:221-229.
12. Esler M and Kaye D (2000) Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics. Heart Fail Rev 5:17-25. (Pubitemid 30301508)
13. Esterbauer H, Schaur RJ, and Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81-128. (Pubitemid 121003917)
14. Franchetti P, Cappellacci L, Marchetti S, Trincavelli L, Martini C, Mazzoni MR, Lucacchini A, and Grifantini M (1998) 2′-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies. J Med Chem 41:1708-1715. (Pubitemid 28221965)
15. 3-selective adenosine agonists. J Med Chem 37:636-646.
16. Hellström E and Tottmar O (1982) Acute effects of ethanol and acetaldehyde on blood pressure and heart rate in disulfiram-treated and control rats. Pharmacol Biochem Behav 17:1103-1109. (Pubitemid 13222252)
17. 2-adrenoceptors. Circ Res 78:475-481.
18. 3-receptors in myocardial ischemia: their role as regulators of exocytotic norepinephrine release. J Pharmacol Exp Ther 271:1259-1266.
19. Inagaki K, Churchill E, and Mochly-Rosen D (2006) Epsilon protein kinase C as a potential therapeutic target for the ischemic heart. Cardiovasc Res 70:222-230.
20. Inagaki K, Hahn HS, Dorn GW 2nd, and Mochly-Rosen D (2003) Additive protection of the ischemic heart ex vivo by combined treatment with δ-protein kinase C inhibitor and ε-protein kinase C activator. Circulation 108:869-875. (Pubitemid 37022131)
21. James TN and Bear ES (1967) Effects of ethanol and acetaldehyde on the heart. Am Heart J 74:243-255.
22. Johnson JA, Gray MO, Chen CH, and Mochly-Rosen D (1996) A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem 271:24962-24966. (Pubitemid 26333253)
23. Julius S (1993) Corcoran Lecture. Sympathetic hyperactivity and coronary risk in hypertension. Hypertension 21:886-893.
24. Kitbunnadaj R, Hashimoto T, Poli E, Zuiderveld OP, Menozzi A, Hidaka R, de Esch IJ, Bakker RA, Menge WM, Yamatodani A, et al. (2005) N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist. J Med Chem 48:2100-2107. (Pubitemid 40396337)
25. Koda K, Salazar-Rodriguez M, Corti F, Chan NY, Estephan R, Silver RB, Mochly-Rosen D, and Levi R (2010) Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells. Circulation 122:771-781.
26. 3-receptors: a new frontier in myocardial ischemia. J Pharmacol Exp Ther 292:825-830.
27. Li AH, Moro S, Melman N, Ji XD, and Jacobson KA (1998) Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. J Med Chem 41:3186-3201. (Pubitemid 28376524)
28. Morrey C, Brazin J, Seyedi N, Corti F, Silver RB, and Levi R (2010) Interaction between sensory C-fibers and cardiac mast cells in ischemia/reperfusion: activation of a local renin-angiotensin system culminating in severe arrhythmic dysfunction. J Pharmacol Exp Ther 335:76-84.
29. 2+ channels. J Pharmacol Exp Ther 326:871-878.
30. Schneider FH (1971) Acetaldehyde-induced catecholamine secretion from the cow adrenal medulla. J Pharmacol Exp Ther 177:109-118.
31. Selwyn AP and Braunwald E (2001) Ischemic heart disease, in Harrison's Principles of Internal Medicine (Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, and Jameson JL eds) pp 1399-1410, McGraw-Hill, New York.
32. Sesti C, Koyama M, Broekman MJ, Marcus AJ, and Levi R (2003) Ectonucleotidase in sympathetic nerve endings modulates ATP and norepinephrine exocytosis in myocardial ischemia. J Pharmacol Exp Ther 306:238-244. (Pubitemid 36734378)
33. 3-receptor-induced attenuation of norepinephrine exocytosis: a decreased protein kinase A activity mediates a reduction in intracellular calcium. J Pharmacol Exp Ther 312:272-280.
34. 2-receptor activation augments norepinephrine exocytosis from cardiac sympathetic nerve endings. Mediation by autocrine/paracrine mechanisms. Circ Res 81:774-784.
35. Thadani PV and Truitt EB Jr (1977) Effect of acute ethanol or acetaldehyde administration on the uptake, release, metabolism and turnover rate of norepinephrine in rat brain. Biochem Pharmacol 26:1147-1150. (Pubitemid 8120023)
36. von der Leyen H, Schmitz W, Scholz H, Scholz J, Lohse MJ, and Schwabe U (1989) Effects of 1,3-dipropyl-8-cyclopentylxanthine (DPCPX), a highly selective adenosine receptor antagonist, on force of contraction in guinea-pig atrial and ventricular cardiac preparations. Naunyn Schmiedebergs Arch Pharmacol 340:204-209. (Pubitemid 19203274)